- NeuroMetrix (NASDAQ:NURO) Q4 results: Revenues: $1.4M (+0.7%); COGS: $0.7M (+40.0%); Operating Expenes: $3.2M (+45.5%); Operating Loss: ($2.4M) (-71.4%); Net Loss: ($2.9M) (+21.6%); Loss Per Share: ($0.36) (+58.6%).
- FY2014 results: Revenues: $5.5M (+3.8%); COGS: $2.6M (+18.2%); Operating Expenses: $11.7M (+12.5%); Operating Loss: ($8.8M) (-18.9%); Net Loss: ($7.8M) (+2.5%); Loss Per Share: ($1.54) (+49.8%); Quick Assets: $9.22M (+0.2%).
- No guidance given.
NeuroMetrix Q4 & FY14 results
Recommended For You
More Trending News
About NURO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NURO | - | - |
NeuroMetrix, Inc. |